[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349485-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-349485-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","germline-apoe-2-homozygosity-and-reduced-risk-of-breast-cancer-a-population-based-cohort-study","Germline APOE ε2 homozygosity and reduced risk of breast cancer - a population-based cohort study","","Evaluate whether APOE ε2 homozygosity, a germline variant linked to lower LDL cholesterol, reduces breast cancer risk. Data from 234,857 women without cancer or dementiafree status in the UK Biobank were analyzed by APOE genotype categories and incident breast cancer identified via national registry linkage. Cox proportional hazards models estimated adjusted hazard ratios with lifestyle, metabolic, and female-specific subgroup analyses. Over a 12.3-year median follow-up, 7,961 first primary breast cancers occurred, with stronger protection in smokers and under inflammatory stress.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/germline-apoe-2-homozygosity-and-reduced-risk-of-breast-cancer-a-population-based-cohort-study/349485/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/germline-apoe-2-homozygosity-and-reduced-risk-of-breast-cancer-a-population-based-cohort-study/349485.png","ImageObject",300,407,{"name":42,"@type":43},"Guten tag","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main research question about APOE ε2 homozygosity and breast cancer?","Question",{"text":63,"@type":64},"The study evaluates whether APOE ε2 homozygosity is linked to a reduced risk of breast cancer compared with non-ε2 carriers, considering APOE-related LDL cholesterol effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was breast cancer incidence determined in the study?",{"text":68,"@type":64},"Incident breast cancer was assessed through national registry linkage after participants were followed for a median of 12.3 years.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about breast cancer risk in ε2 homozygotes?",{"text":72,"@type":64},"Compared with non-ε2 carriers, ε2 homozygotes showed significantly lower breast cancer risk (adjusted HR 0.64; 95% CI 0.45–0.90).",{"name":74,"@type":61,"acceptedAnswer":75},"Did the association vary across subgroups?",{"text":76,"@type":64},"Yes. The protective association of ε2/ε2 was stronger among participants with a smoking history and was particularly observed under inflammatory stress.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},349485,1790377086,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":121,"preview_page_count":33,"preview_urls":148},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Woo et al. Breast Cancer Research (2026) 28:129 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-026-02308-6](https://doi.org/10.1186/s13058-026-02308-6)  \nRESEARCH Open Access  \nGermline APOE ε2 homozygosity and reduced  risk of breast cancer: a population-based  \ncohort study  \nHwamin Woo1,2†, Suhyun Han3†, Jihye Heo1,2, Juhee Cho1,2, Do-Geun Kim4*†, Chi-Hun Kim5*† and Danbee Kang1,2,6*†  \nAbstract  \nWe evaluated whether Apolipoprotein E (APOE) ε2 homozygosity, a germline variant associated with lower LDL cholesterol, is linked to reduced risk of breast cancer. We analyzed data from 234,857 cancer-free and dementiafree women in the UK Biobank. APOE genotypes were classified as ε2 homozygotes, ε2 heterozygotes, and non-ε2 carriers. Incident breast cancer was assessed via national registry linkage. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) . Subgroup analyses were conducted by lifestyle, metabolic, and female-specific factors. Over a median follow-up of 12.3 years, 7,961 first primary breast cancers occurred. Compared to non-ε2 carriers, ε2 homozygotes had significantly lower breast cancer risk (HR, 0. 64; 95% CI 0.45– 0. 90) . The protective association of ε2/ε2 was stronger in participants with smoking history. APOE ε2 homozygosity was associated with reduced risk of breast cancer, particularly under inflammatory stress. These findings suggest that genetically determined lipid and inflammatory regulation may influence breast cancer susceptibility. Keywords APOE, breast cancer, lipid metabolism, genetic epidemiology, UK biobank  \nIntroduction  \nLipid metabolism is a key regulator of the tumor microenvironment [1] Lipid substrates for membrane biosynthesis, energy metabolism, and oncogenic signaling are numerous in cancer cells, and many cancers are sensitive to drugs that inhibit lipid uptake or synthesis [1]. Among various malignancies, breast cancer has been particularly  \n\n| †Hwamin Woo BS and Suhyun Han BS have contributed equally to this work as first authors. |\n| --- |\n| †Do-Geun Kim, Chi-Hun Kim and Danbee Kang contributed equally to this work. |\n\n*Correspondence:  \nDo-Geun Kim kimvet091 [1@kbri. re.kr](1@kbri. re.kr)[ ](1@kbri. re.kr)Chi-Hun Kim[chi-hun.kim@hotmail.com](chi-hun.kim@hotmail.com)[ ](chi-hun.kim@hotmail.com)Danbee Kang [dbee.kang@skku.edu](dbee.kang@skku.edu)  \nshown to exhibit an intricate dependency on lipid metabolism, and as such has been highlighted for potential therapeutic intervention [2, 3].  \nIn this perspective, germline genetic drivers of lipid metabolism could provide novel options for risk stratification and metabolic prevention interventions [4]. Among apolipoprotein family genes, Apolipoprotein E  \n1Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea  \n2Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Republic of Korea  \n3Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea  \n4Dementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea  \n5Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea  \n6Trend Sensing and Risk Modeling Center, Institution of Quality of Life in Cancer, Samsung Medical Center, Seoul, Republic of Korea  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the art","cbCaijNTMf5uvVXA","https://ap.wps.com/l/cbCaijNTMf5uvVXA","pdf",1313649,"English","# Abstract\n# Introduction\n## Study background and rationale\n# Baseline characteristics\n## Table 1","[{\"question\":\"What is the main research question about APOE ε2 homozygosity and breast cancer?\",\"answer\":\"The study evaluates whether APOE ε2 homozygosity is linked to a reduced risk of breast cancer compared with non-ε2 carriers, considering APOE-related LDL cholesterol effects.\"},{\"question\":\"How was breast cancer incidence determined in the study?\",\"answer\":\"Incident breast cancer was assessed through national registry linkage after participants were followed for a median of 12.3 years.\"},{\"question\":\"What did the study find about breast cancer risk in ε2 homozygotes?\",\"answer\":\"Compared with non-ε2 carriers, ε2 homozygotes showed significantly lower breast cancer risk (adjusted HR 0.64; 95% CI 0.45–0.90).\"},{\"question\":\"Did the association vary across subgroups?\",\"answer\":\"Yes. The protective association of ε2/ε2 was stronger among participants with a smoking history and was particularly observed under inflammatory stress.\"}]","Germline APOE ε2 homozygosity and reduced risk of breast cancer - a population-based cohort study | PDF",1790083506,[149,153,157,161],{"page_no":22,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8307e5eee117d143f0639a7c022955f1.webp",983,1310,{"page_no":26,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99e1f57dd892b7d306232cc453468403.webp",982,1309,{"page_no":30,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e3fec8895a5af1dad0537fe1c8c8ba4.webp",981,1308,{"page_no":33,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c51343989877e9a6eece3ac26151675.webp",980,1306]